Lipase variants and polynucleotides encoding same

Patent metadata

Field	Value
Publication number	US-10920205-B2
Application number	US-201916439912-A
Country	US
Kind code	B2
Filing date	Jun 13, 2019
Priority date	May 27, 2014
Publication date	Feb 16, 2021
Grant date	Feb 16, 2021

Abstract

The present invention relates to a lipase variant of a parent lipase, which variant has lipase activity, at least 75% but less than 100% sequence identity to SEQ ID NO: 3 and comprises a substitution at one or more positions corresponding to positions 1; 2; 3; 4; 5; 6; 7; 9; 10; 11; 12; 16; 19; 30; 31; 34; 36; 37; 39; 40; 42; 44; 51; 52; 53; 54; 56; 58; 59; 70; 71; 72; 73; 83; 84; 86; 88; 90; 92; 93; 95; 96; 100; 101; 102; 104; 106; 109; 110; 112; 117; 119; 124; 125; 127; 128; 131; 132; 133; 134; 135; 137; 158; 159; 160; 161; 162; 163; 165; 166; 167; 168; 170; 181; 182; 183; 189; 190; 192; 194; 196; 202; 210; 211; 212; 220; 225; 227; 228; 229; 230; 231; 233; 237; 238; 239; 240; 242; 246; 247; 248; 252; 259; 262; 264; 269 of SEQ ID NO: 3. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

First claim

The invention claimed is:

1. A lipase variant which has lipase activity, at least 85% but less than 100% sequence identity to SEQ ID NO: 3, and comprises an amino acid substitution at position 1 of SEQ ID NO: 3.

2. The lipase variant of claim 1 , wherein the substitution at position 1 of SEQ ID NO: 3 is C,F,G,H,I,L,M,P,Q,R,V,W, or Y.

3. The lipase variant of claim 1 having at least 90% but less than 100% sequence identity to the polypeptide of SEQ ID NO: 3.

4. The lipase variant of claim 1 , wherein the variant has one or more improved properties relative to the polypeptide of SEQ ID NO: 3, measured as an Improvement Factor (IF) that is greater than 1.0, wherein the improved properties are selected from the group consisting of: Thermostability; Thermostability in Detergent; Hydrolytic Activity in Detergent; and Stability in Detergent.

5. The lipase variant of claim 4 , wherein the Improvement Factor (IF) is greater than 1.0 in at least one of the assays selected from the group consisting of: A Thermostability Assay; B Thermostability in Detergent Assay; C Performance Screening Assay; and D Stability in Detergent Assay.

6. The lipase variant of claim 4 , wherein the Improvement Factor (IF) is greater than 1.0 in at least two assays selected from the group consisting of: A Thermostability Assay; B Thermostability in Detergent Assay; C Performance Screening Assay; and D Stability in Detergent Assay.

7. The lipase variant of claim 4 , wherein the Improvement Factor (IF) is at least 1.5.

8. The lipase variant of claim 1 , which further comprises an amino acid substitution at one or more positions corresponding to positions: ABT; Y28LC; 141T; C43S; D48E; K50E; Y60AC; D61NKRAVLSTC; R800; S84C; I86C; N87C; A900; D91NKRAVLST; F94LTK; S98P; S103R; D113NKRAVLST; S1140; G116V; N120KD; K131F; G156D; N186Y; E201QKRAVLST; I204VATSG; V205IL; L208VATSG; F213VATSG; H217N; D226NKRAVLST; T236A; T241S; D243NKRAVLSTH; V254IATSG; L255VATSG; D256NKRAVLST; L258VATSG; Y260WCGV; and L267VATSG of SEQ ID NO: 3.

9. A method of hydrolyzing a lipase substrate, comprising contacting said substrate with the lipase variant of claim 1 .

10. A composition comprising the lipase variant of claim 1 .

11. A method of producing a composition comprising adding the lipase variant of claim 1 to the composition.

12. A method of cleaning, comprising contacting a surface or an item with the composition according to claim 10 .

13. A method for obtaining the lipase variant of claim 1 , comprising introducing an amino acid substitution at one or more positions corresponding to position 1 of SEQ ID NO: 3, wherein the variant has lipase activity; and recovering the lipase variant.

14. The lipase variant of claim 1 having at least 95% but less than 100% sequence identity to the polypeptide of SEQ ID NO: 3.

15. The lipase variant of claim 1 , which further comprises a substitution selected from the group consisting of: 2(A,C,D,M,N,P,Q,R,S,T,V); 3(A,E,G,K,Q,S,T,V); 4(A,P,Q,R,S,T); 5(E,K,S,T,V,Y); 6(A,H,K,N,P,Q,R,S,V,W); 7(P); 8(C,G,H,N,P,Q,R,S,W,Y); 9(Y); 10(G,R,S,Y); 11(G, H,I, L, P,Q, R,T); 12(A,I,K,L,M,N,R,S,T); 16(P, R,S,T,W); 19(C, E, H, L,W,T); 30(A, F, H, I, L, N, P,S,T,V,W); 31(A,C, D, E, F,G, H, I, K, P,Q, R,S,V); 34 (A,G,V); 36(D, E,G,K,Q,R,S,V); 37(A, E, G,S,V); 39(F, K, L, N,S); 41(A, D, E, G, H, K, L, P, Q, R,S,V,W); 42(A, E, G, K, L,M, R,S,T,V); 44 (A, C, E,G, H,K,M, P, Q, R, S, V, VV); 51(A, D,G, H, K, L, M,V,Y); 52(L,V); 53(A, D,G, H, I, L, M, P,Q,R,S,V); 54(A, D, E,G, I,K, L,S,V); 56(A, P,Q, R,T,V,W); 58(C,G, I, P, R,S,V,W); 59(A,D,F,G,H,L,M,P,R,S,T,V); 61(G,M); 70(A,E,G,R); 71(E, K, N,Q, R,W,Y); 72 (A, C, D, G, K, R, S, T, V); 73(E, G, L,N,Q,R,S,T); 83(A); 84(A, E, L,P,W,Y); 86(A, G, I,K,M,W); 88(M,Q,R,S); 90(D, F,G, L,S, T,V,W); 91(E, F,G,Q,Y); 92(A,C,D,F,P,S,T,V,W); 93(A, I, R,V); 95(C,G,I,Q,R,S); 96(A,C,D,E,G,N,Q,R,S,W,Y); 98(A,D,E,G,K,N,R,T,V,W); 100(A,E,G,K,L,R,S,V,W); 101(D,H,R,S,V); 102(H,I,P,R,S); 103(A,C,D,F,G,L,P,V); 104(A, C, D, E, K, L,M, P,Q, R,V,W,Y); 106(A, C, G, L, P, Q, R,S,T,W); 109(A, D, E, G, H, L, N, P,Q, R,S,T); 110(C,P,S,V); 112(F,H,Q,R,W); 113(M,W); 116(A,C,D,F,R,S,T); 117(A,D,G,N,P,R,S,V); 119(D,E,F,I,R,S,T,V); 120(A, E, G, H, L,M,S,T,V,Y); 124(C, D, G, H, L,M,Q,R,S,V,W); 127(A,F,G,H,I,Q,R,S,V,Y); 128(A,E,G,H,M,Q,S,T); 131(A,G,I,M,S,T,V,W); 132(G,S,V); 133(A,E,K,L,M,R,V,W); 134(A,D,E,G,K,R,S,T,V); 135(A,C,G,P,Q,R,T,V,W,Y); 137(A,F,G,P,R); 158(A,C,G,I,L,N,R,S,T,V,W); 159(G,T); 160(A,D,G,I,L,Q,V); 161(C,G,I,K,L,P,Q,R,S); 162(A,D,G,L,M,P,R,S,V,W); 163(A,D,E,H,L,M,Q,V,Y); 165(A,C,G,K,L,M,P,R,V,W); 166(A,C,E,G,LP,R,W); 167(C,F,H,I,L,M,R,V); 168(A,C,D,G,R,S,V,W); 170(A,C,E,G,H,I,K,L,M,Q,R,S,V,W,Y); 181(A,C,E,G,L,Q,R,S,V,W); 182(A, C, F, G, I, L, R, S, T, V,W,Y); 183(E, V); 186(A, C, E, G, H, K, L, R,S,T,W); 189(A, C, G, L, M, P, R, S); 190(A, E,G, I, K, N, R, V, VV); 192 (A, I, L, M, P, R, T, V); 194(A, D, E, F,G, H, L, Q, T, V); 196(A, Q,Y); 201(D,G,L,P); 202(I,M); 204(E,K,L,P,R); 208(E,M,P,R,W); 210(A,F,L,Q); 211(C,E,G,P,S,V,W); 212(D,E,G,H,K,N,P,Q,R,S,T,V,W); 213(E,H,L,M,P,Q,R,W); 220(A,C,D,G,L,P,R,S,T,W); 225(A,L,M,P,Q,S); 226(C,E,F,G,P,R,W,Y); 227(A,C,G,P,R,S,V,W); 228(A,C,D,G,L,P,R,V,W); 229(A,I,L,N,R,S,T); 230(A,G,H,L,P,Q,R,S,T,V,W); 231(A,C,G,H,K,R,S,V,W,Y); 233(A,F,H,L,M,S,T); 236(C,L,P,S,V); 237(F,G,H,L,M,N,R,V); 238(A,E,F,G,H,M,P,R,S,V,W); 239(F,G,S,Y); 240(A); 241(M,V); 242(A,C,G,I,L,M,P,R,T,V,Y); 243(A,C,E,F,G,M); 246(A,E,K,P,S,T,V); 247(A,E,L,P,T,Y); 248(A,G,P,V); 252(A,D,E,G,N,Q,S,V); 255(C,E,M,Q,R); 259(A,C,D,E,G,I,K,L,M,Q,R,T,V,W,Y); 262(A,D,E,K,M,R,T,V); 264(C,G,I,L,M,P,R,S,T); 267(E,H,K,M,Q,W); and 269(A,D,E,G,H,K,L,M,N,Q,R,S,V,Y).

Assignees

• Novozymes As

Inventors

• Balumuri Padmavathi
• Saikia Rakhi
• Svendsen Allan
• Baunsgaard Lone

Classifications

• C12P7/6418

  by hydrolysis of fatty acid esters · CPC title

• C11D3/38627

  containing lipase · CPC title

• C12Y301/01003

  Triacylglycerol lipase (3.1.1.3) · CPC title

• C12N9/20 Primary

  Triglyceride splitting, e.g. by means of lipase · CPC title

• C12N15/09

  Recombinant DNA-technology · CPC title